Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia

Phase 2 Not yet recruiting 18 enrolled CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is a multicenter, open-label, phase II clinical study, aiming to evaluate the efficacy and safety of SYH2070 injection in participants with HoFH.

Timeline

Start: 2026-05-24
Primary completion: 2027-09-16
Completion: 2027-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SYH2070	Unknown	—	—

Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia

Summary

Timeline

Drugs

Indications